Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benign Reproductive Tissue Evaluation (BRTE) Study

NCT00481754 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00481754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00481754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benign Reproductive Tissue Evaluation (BRTE) Study
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
April 24, 2006
Completion date
November 13, 2020
Enrollment
359 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hysterectomy, oophorectomy for benign reasons